Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
This month, Nature Reviews Cancer launches Tools of the Trade articles, in which early career researchers can discuss the methods or techniques that they use to conduct their research.
In an effort to bring to our pages some of the vibrant discussion of cancer research that happens during in-person or online journal club meetings, we are now publishing Journal Clubs — an article type in which researchers discuss research papers of their choice with the intention of alerting our readers to articles that have a special significance to them and the field.
This issue marks the 20th anniversary of Nature Reviews Cancer. On this milestone birthday we both look back on the past 20 years of cancer research and look forward to the future.
This Focus issue highlights current research into the unique biology of brain tumours and brain metastasis and how this research might improve therapy of these often devastating diseases.
Beyond the laboratory bench, cancer researchers will face big challenges during their careers. Nature Reviews Cancer has published two Viewpoint articles to highlight some of these wider issues.
How does a Nature Reviews Cancer Review or Perspectives article move from an idea to a published article? Here, in the spirit of transparency, we provide some insights into this process.
Recent data on blood-based tests for early cancer detection are promising, but many issues must be addressed before we have clinically useful blood-based screening tests.
This issue marks the publication of a Consensus Statement that proposes a classification system for the evolutionary and ecological features of cancers.
As we begin 2013 it's time to take stock of what we do know and what we don't, and consider how best to approach finding new treatments for cancer. Do we embrace complexity or go back to basics?
